Savara (SVRA) Capital Leases (2015 - 2018)

Savara (SVRA) reported Capital Leases of $297000.0 for Q1 2018, up 642.5% year-over-year from $40000.0 in Q1 2017, and little changed on a QoQ basis from $297000.0 in Q4 2017.

Savara (SVRA) has 4 years of Capital Leases data on file, last reported at $297000.0 in Q1 2018.

  • Quarterly Capital Leases rose 642.5% year-over-year to $297000.0 in Q1 2018, while the trailing twelve-month figure through Mar 2018 was $297000.0 (up 642.5% YoY) and the FY2017 annual result came in at $297000.0, down 48.7% from the prior year.
  • Capital Leases was little changed at $297000.0 in Q1 2018 per SVRA's latest filing, from $297000.0 in the prior quarter.
  • Across five years, Capital Leases topped out at $35.0 million in Q1 2015 and bottomed at $19000.0 in Q3 2016.
  • The 4-year median for Capital Leases is $297000.0 (2017), against an average of $5.5 million.
  • Peak annual rise in Capital Leases reached 2216.0% in 2016, while the deepest fall reached 99.93% in 2016.
  • Tracing SVRA's Capital Leases over 4 years: stood at $25000.0 in 2015, then jumped by 2216.0% to $579000.0 in 2016, then slumped by 48.7% to $297000.0 in 2017, then changed by 0.0% to $297000.0 in 2018.
  • Per Business Quant, the three latest SVRA Capital Leases figures stand at $297000.0 (Q1 2018), $297000.0 (Q4 2017), and $297000.0 (Q3 2017).

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Quantum Biopharma 961,148.99 Bn 961,148.98 Bn -
2 Alterity Therapeutics 744,933.29 Bn 744,933.26 Bn -
3 Legend Biotech 2,540.00 Bn 2,539.71 Bn 242.10 Mn
4 Nanobiotix 2,199.85 Bn 2,199.78 Bn -
5 Akari Therapeutics 1,635.88 Bn 1,635.88 Bn -
6 Vertex Pharmaceuticals 111.32 Bn 104.07 Bn 2.59 Bn
7 Evaxion A 62.56 Bn 62.54 Bn -
8 Regeneron Pharmaceuticals 62.55 Bn 53.79 Bn 3.31 Bn
9 Alnylam Pharmaceuticals 39.57 Bn 36.56 Bn 959.66 Mn
10 Savara 1.30 Bn 1.30 Bn -

Historic Data

Download Data 🔒
DateValue
Mar 31, 2018 297,000.00
Dec 31, 2017 297,000.00
Sep 30, 2017 297,000.00
Jun 30, 2017 297,000.00
Mar 31, 2017 40,000.00
Dec 31, 2016 579,000.00
Sep 30, 2016 19,000.00
Jun 30, 2016 40,000.00
Mar 31, 2016 24,000.00
Dec 31, 2015 25,000.00
Sep 30, 2015 24,000.00
Jun 30, 2015 35.00 Mn
Mar 31, 2015 35.00 Mn